FDA Advisory Committee Votes in Favor of Romosozumab Approval

Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.

Reference

1. Amgen. News release: Amgen and UCB receive positive vote from FDA advisory committee in favor of approval for Evenity (romosozumab). 2019 Jan 16.